References
- Antonelli A, Ferrari SM, Ragusa F, et al. Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab. 2020; 34(1):101-110.
- Wémeau J, Klein M, Sadoul JL, et al. Graves’ disease: Introduction, epidemiology, endogenous and environmental pathogenic factors. Ann Endocrinol. 2018;79(6):599-607.
- Iddah MA, Macharia BN. Autoimmune thyroid disorders. ISRN Endocrinol. 2013; 2013:509764.
- Antonelli A, Fallahi P, Elia G, et al. Graves’ disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab. 2020; 34(1):101388.
- Kahaly GJ, Bartalena L, Hegedüs L, et al. 2018 European thyroid association guideline for the management of Graves’ hyperthyroidism. Eur Thyroid J. 2018; 7(4):167-186.
- Jansson S, Berg’ G, Lindstedt G, et al. Overweight-a common problem among women treated for hyperthyroidism. Postgrad Med J. 1993; 69(808):107-111.
- Dale J, Daykin J, Holder R, et al. Weight gain following treatment of hyperthyroidism. Clinical Endocrinology. 2001; 55(2):233-239.
- O’malley B, Hickey J, Nevens E, et al. Thyroid dysfunction – weight problems and the psyche: the patients’ perspective. J Hum Nutr Diet. 2008; 13(4):243-248.
- Brunova J, Bruna J, Joubert G, et al. Weight gain in patients after therapy for hyperthyroidism. S Afr Med. 2003; 93(7):529-531.
- Kyriacou A, Makris KC, Syed AA, et al. Weight gain following treatment of hyperthyroidism – A forgotten tale. Clin Obes. 2019; 9(5):e12328.
- Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep. 2003; 5(6):513-520.
- Rizos CV, Elisaf MS, Liberopoulos EN. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J. 2011;5:76-84
- Potenza M, Via MA, Yanagisawa RT. Excess thyroid hormone and carbohydrate metabolism. Endocr Pract. 2009; 15(3):254-262.
- Dobrowolski P, Prejbisz A, Kurylowicz A, et al. Metabolic syndrome a new definition and management guidelines. Arch Med Sci. 2022; 18(5):1133-1156.
- Alberti K, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention. 2009; 120(16):1640-1645.
- Elabbassi WN, Haddad HA. The global epidemic of metabolic syndrome. Saudi Med J. 2005; 26(3):373-375.
- Scuteri A, Laurent S, Cucca F, et al. The metabolic syndrome across Europe – different clusters of risk factors. Metabolic syndrome and Arteries REsearch (MARE). Eur J Prev Cardiol. 2015; 22(4):486-491.
- Kuk JL, Ardern CI. Age and sex differences in the clustering of metabolic syndrome factors: Association with mortality risk. Diabetes Care. 2010; 33(11):2457-2461.
- Sengupta J, Das H, Chellaiyan D VG, et al. An observational study of incidence of metabolic syndrome among patients with controlled Grave’s disease. Clin Epidemiol Glob Heal. 2022; 15(5):101010.
- Krishnamoorthy Y, Rajaa S, Murali S, et alr SS. Prevalence of metabolic syndrome among the adult population in India: A systematic review and meta-analysis. PLoS One. 2020; 15(10):1-25.
- Borissova A-M, Shinkov A, Vlahov J, et al. Metabolic syndrome in Bulgarian population in 2012 year. Endocrinologia. 2015; 20(3):144-152.
- Borissova A-M, Kovatcheva R, Shinkov A, et al. Prevalence and features of the metabolic syndrome in unselected Bulgarian population. Endocrinologia. 2007; 12(2):68-77.
- Borissova A-M, Shinkov A, Vlahov J, et al. Features of metabolic syndrome in Bulgarian population. Endocrinologia. 2015; 20(3):153-162.
- Lin X, Xu Y, Pan X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020; 10(1):1-11.
- Cowie CC, Casagrande SS, Menke A, et al. Prevalence and Incidence of Type 2 Diabetes and Prediabetes. In: Diabetes in America 3rd ed. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018.
- Borissova A-M, Shinkov A, Vlahov J, et al. Prevalence of arterial hypertension in Bulgarian population (actual data). Endocrinologia. 2015; 20(2):76-81.
- Borissova A-M, Shinkov A, Vlahov J, et al. Dyslipidemia – prevalence in Bulgarian population today. Endocrinologia. 2015; 20(3):163-173.
- Snijder MB, Zimmet PZ, Visser M, et al. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: The AusDiab Study. Int J Obes. 2004; 28(3):402-409.
- Jaeschke L, Steinbrecher A, Pischon T. Measurement of waist and hip circumference with a body surface scanner: Feasibility, validity, reliability, and correlations with markers of the metabolic syndrome. PLoS One. 2015; 10(3):1-16.
- Hu L, Huang X, You C, et al. Prevalence of overweight, obesity, abdominal obesity and obesity-related risk factors in southern China. PLoS One. 2017; 12(9):1-14.
- Jura M, Kozak LP. Obesity and related consequences to aging. Age. 2016; 38(1):23-30.
- Cooper A, Gupta S, Moustafa A, et al. Sex/Gender Differences in Obesity Prevalence, Comorbidities, and Treatment. Curr Obes Rep. 2021; 10(4):458-466.
- Borissova A-M, Shinkov A, Vlahov J, et al. Prevalence of diabetes mellitus and prediabetes in Bulgaria today. Endocrinologia. 2012; 17(4):182-192.
- Kumar DV, Mathur DSL, Tuteja DRK. Effects of Thyroid Dysfunction on Lipid Profile. Int J Med Biomed Stud. 2019; 3(6):76-84.
- Zhang L, Evans A, von Ruhland C, et al. Distinctive features of orbital adipose tissue (Oat) in Graves’ orbitopathy. Int J Mol Sci. 2020; 21(23):1-17.
- Khanna D, Khanna S, Khanna P, et al. Obesity: A Chronic Low-Grade Inflammation and Its Markers. Cureus. 2022; 14(2): e22711.
- Lozanov L. Association between thyroid function and adipose tissue. Endocrinologia. 2015; 20(3):125-138.